Taken together, it is intriguing to profoundly explore whether melatonin inhibits glioma cell migration and invasion under hypoxia via regulating ROS level, consequently modulating αvβ3 integrin expression and the activation of FAK and Pyk2. Here, PTK2 is linked to central nervous system cancer.